Log in

DPHARMA Duopharma Biotech Bhd. MYX · Malaysia

Duopharma Biotech Bhd. (DPHARMA) news

Duopharma Biotech Bhd. is a public biotech or pharmaceutical company listed on MYX under the ticker DPHARMA, recorded under Malaysia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Duopharma Biotech Bhd. news

We have not published a story on Duopharma Biotech Bhd. yet. When there is news, it will appear here.

Questions about Duopharma Biotech Bhd.

What is the ticker symbol of Duopharma Biotech Bhd.?

Duopharma Biotech Bhd. trades under the ticker DPHARMA on MYX.

Where is Duopharma Biotech Bhd. listed?

Duopharma Biotech Bhd. is listed on MYX.

Which country or territory is Duopharma Biotech Bhd. listed under?

Our directory records Duopharma Biotech Bhd. under Malaysia.

What does Duopharma Biotech Bhd. do?

Our directory classifies Duopharma Biotech Bhd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Duopharma Biotech Bhd.?

The ISIN recorded for Duopharma Biotech Bhd. is MYL7148OO009.

Does aibio.space cover Duopharma Biotech Bhd.?

aibio.space lists Duopharma Biotech Bhd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Duopharma Biotech Bhd.?

Companies in our directory listed in the same country and business area as Duopharma Biotech Bhd.: Y.S.P. Southeast Asia Holding Bhd., Bio Green Med Solution, Kotra Industries Bhd., Pharmaniaga Bhd..

Investor discussion: Duopharma Biotech Bhd.

Members talk about Duopharma Biotech Bhd. (DPHARMA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open MYX:DPHARMA on TradingView.

Listing details

Duopharma Biotech Bhd. is a public biotech or pharmaceutical company listed on MYX under the ticker DPHARMA, recorded under Malaysia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Duopharma Biotech Bhd.
Ticker
DPHARMA
Listing
MYX
Country or territory
Malaysia
Business scope
Pharmaceuticals: Major
ISIN
MYL7148OO009
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.